Effectiveness of Noninvasive Brain Stimulation Protocols on Drug Craving and Consumption/Relapse in Substance Use Disorders: A Systematic Review and Meta-analysis of 208 Clinical Trials and 36 Protocols

This systematic review and meta-analysis of 208 clinical trials demonstrates that noninvasive brain stimulation techniques, particularly high-frequency TMS and tES targeting the frontopolar and DLPFC regions, produce medium-to-large effects in reducing drug craving and consumption in substance use disorders, with high-frequency deep TMS using the H4 coil showing the strongest efficacy.

The Gist

Imagine your brain is a bustling city. In a healthy city, traffic flows smoothly, and the "mayor" (the prefrontal cortex) keeps things in order, making sure you don't do risky things like running a red light.

But in Substance Use Disorders (SUDs), the city is in chaos. The "drug craving" is like a massive, screaming siren that drowns out the mayor's voice. The traffic lights are broken, and the citizens (your neurons) are stuck in a loop of wanting the drug, taking it, and then regretting it, only to do it all again.

For a long time, doctors have tried to fix this city with medication (chemicals). But for many addictions, there aren't enough good chemicals to fix the broken traffic lights. That's where Noninvasive Brain Stimulation (NIBS) comes in. Think of NIBS as a remote control or a tuning fork that doctors can use to gently "tune" the brain's radio frequency back to a healthy station without opening up the skull.

This paper is a massive report card on how well these "brain remotes" work. The researchers didn't just test one remote; they looked at 208 different clinical trials involving over 10,000 people to see which settings work best.

Here is the breakdown of their findings, translated into everyday language:

1. The Two Main Types of "Remotes"

The study looked at two main ways to send signals to the brain:

• TMS (Transcranial Magnetic Stimulation): Imagine a magnetic wand that hovers over the head. It uses a strong magnetic pulse (like a gentle, rhythmic tap) to wake up or calm down specific brain cells.
• tES (Transcranial Electrical Stimulation): Imagine a gentle electrical current (like a very mild battery) flowing through the scalp. It's like a "nudge" to the brain's electrical system.

2. The Big Result: It Works!

The researchers found that both the "magnetic wand" and the "electrical nudge" are effective.

• Craving: Both methods significantly reduced the "screaming siren" of drug cravings. It's like turning the volume down on the siren so the mayor can finally speak again.
• Relapse/Consumption: They also helped people stop using drugs or relapse less often. The "magnetic wand" (TMS) seemed slightly better at stopping the actual use of drugs, while both were good at stopping the wanting of drugs.

3. Finding the "Perfect Frequency" (The Protocols)

Just like a radio, if you are slightly off the frequency, you only get static. The researchers tested 36 different settings (protocols) to find the "Goldilocks" zone—not too hot, not too cold, but just right.

• The "Deep" Magic (The H4 Coil): The absolute winner was a specific type of magnetic stimulation called Deep TMS using a special H4 coil.

  • Analogy: Think of standard TMS as a flashlight that only lights up the surface of a table. The H4 coil is like a spotlight with a deep beam that shines all the way down into the basement of the brain (specifically the areas that control how much we value rewards and how we feel).
  • Result: This single study showed a massive effect, almost like finding the "master key" to the addiction lock.

• The "Standard" Hero (Left DLPFC): The next best thing was the standard high-frequency TMS over the Left DLPFC (a part of the forehead).

  • Analogy: This is like the City Mayor's office. Stimulating this area helps the "mayor" regain control over the chaotic traffic. It's the most common setting used and works very well.

• The Electrical Nudge (tDCS): For the electrical current, the best setup was placing the positive electrode on one side of the forehead and the negative on the other (bilateral).

  • Analogy: This creates a "bridge" of electricity across the front of the brain, helping the two sides talk to each other better and calm down the cravings.

4. What This Means for the Future

This paper is like a map for treasure hunters. Before this, doctors were guessing which "remote" setting to use. Now, we know:

1. It works: These brain remotes are a real, effective tool for addiction.
2. Location matters: You have to hit the right spot (the front of the brain) to get the best results.
3. Depth matters: Sometimes you need to go deeper (like the H4 coil) to fix the root of the problem.

The Bottom Line:
Addiction is a broken radio in the brain. This study proves that with the right "tuning" (using TMS or tES), we can fix the static, turn down the volume on the cravings, and help the brain's "mayor" take back control. While we still need more research to perfect the settings for every single person, this is a huge step toward a future where addiction treatment isn't just about willpower or pills, but about rewiring the brain itself.

Technical Summary

1. Problem Statement

Substance Use Disorders (SUDs) represent a critical global health challenge with limited effective pharmacotherapies, particularly for methamphetamine and cannabis use disorders. While Noninvasive Brain Stimulation (NIBS) techniques—specifically Transcranial Magnetic Stimulation (TMS), Transcranial Electrical Stimulation (tES), and Transcranial Focused Ultrasound (tFUS)—have shown promise in modulating neural circuits associated with addiction, the field suffers from significant heterogeneity.

• The Gap: There is no consensus on which specific stimulation protocols (frequency, intensity, target region, coil/electrode type) are most effective for reducing drug craving versus actual consumption or relapse. Previous reviews often focused on specific substances (e.g., only alcohol or nicotine) or lacked granular protocol-level analysis.
• Objective: To quantify the overall efficacy of NIBS on SUD outcomes and identify the optimal stimulation protocols by analyzing the entire parameter space of existing clinical trials.

2. Methodology

The authors conducted a living systematic review and meta-analysis following PRISMA guidelines, with data extracted up to January 1, 2024.

• Data Sources & Scope:
  • Search: PubMed database search for TMS, tES, and tFUS interventions in SUDs.
  • Inclusion: 208 clinical trials were identified (121 TMS, 86 tES, 1 tFUS).
  • Meta-Analysis Subset: 116 randomized sham-controlled trials (59 TMS, 57 tES) with low risk of bias were selected for quantitative analysis.
  • Participants: Total of 10,020 participants (5,106 active stimulation, 4,914 sham).
• Outcome Measures:
  • Primary: Drug craving (subjective) and Consumption/Relapse (objective/behavioral).
  • Effect Size Metric: Hedges' g (random-effects models) comparing active vs. sham groups. Positive values indicate greater reduction in craving/consumption in the active group.
• Risk of Bias: Assessed using the Cochrane Risk of Bias 2 (RoB 2) tool.
• Subgroup Analyses: Performed to dissect the effects of specific parameters:
  • Stimulation type (TMS vs. tES).
  • Target regions (DLPFC, Frontopolar, Insula, etc.).
  • Protocols (Frequency, coil type, electrode montage, session number).
  • Substance types (Nicotine, Alcohol, Opioids, etc.).

3. Key Contributions

• Largest Dataset to Date: This is the most comprehensive meta-analysis in the field, covering 208 trials across 21 countries and multiple substance types, surpassing previous reviews that were limited to specific substances or fewer trials.
• Protocol-Level Granularity: Unlike prior studies that aggregated results, this review performed a deep-dive subgroup analysis of 36 distinct stimulation protocols, identifying specific "winning" combinations of coil type, target, and frequency.
• Electric Field Modeling: The authors integrated computational head models to visualize the maximum electric field distribution for top-performing protocols, linking clinical outcomes to specific neuroanatomical targets (e.g., Frontopolar Cortex vs. DLPFC).
• Living Review Infrastructure: The study is part of the International Network of tES and TMS for Addiction Medicine (INTAM), with a commitment to annual updates and a public OSF repository for data transparency.

4. Key Results

A. Overall Efficacy

• TMS: Demonstrated medium effect sizes for both craving ($g = 0.52$) and consumption/relapse ($g = 0.41$).
• tES: Demonstrated a medium effect on craving ($g = 0.40$) but only a small effect on consumption/relapse ($g = 0.27$).
• tFUS: Only one study was included; insufficient data for meta-analysis.

B. Most Effective Protocols (Subgroup Analysis)

The analysis identified specific protocols with the highest efficacy:

1. Deep TMS (dTMS) with H4 Coil:
   • Target: Anterior Cingulate Cortex (ACC) and bilateral Insula (Salience Network).
   • Result: The strongest effect size observed in the entire meta-analysis ($g = 3.92$ for craving; $g = 1.12$ for consumption).
   • Note: Based on a single study, requiring replication, but it is the only protocol currently FDA-cleared for smoking cessation.
2. High-Frequency rTMS (10 Hz) over Left DLPFC:
   • Result: Significant medium effects for both craving ($g = 0.66$) and consumption ($g = 0.52$). Supported by 21 studies.
3. Bilateral tDCS over DLPFC:
   • Montage: Anodal-Right/Cathodal-Left ($g = 0.49$ craving, $g = 0.42$ consumption) and Anodal-Left/Cathodal-Right ($g = 0.38$ craving, $g = 0.31$ consumption).
   • Mechanism: These montages maximize the electric field over the Frontopolar Cortex (FPC), suggesting FPC modulation is critical for tES efficacy.

C. Substance-Specific Findings

• tES: Most effective for Opioids, Nicotine, and Polysubstance use.
• TMS: Effective for Nicotine, Cocaine, Amphetamines, and Opioids.
• Alcohol: No significant effects were found in the meta-analysis for alcohol use disorder, likely due to protocol heterogeneity or insufficient high-quality trials.

D. Session Duration

• TMS: Multi-session protocols were significantly more effective for reducing consumption than single sessions.
• tES: Single-session protocols showed significant effects on craving, but multi-session protocols did not consistently outperform them for consumption, possibly due to high dropout rates in long-term SUD trials.

5. Significance and Implications

• Clinical Translation: The findings provide evidence-based guidance for clinicians selecting NIBS protocols. Specifically, High-Frequency rTMS over the Left DLPFC is a validated, widely available standard, while Deep TMS (H4 coil) targeting the salience network shows the highest potential efficacy (though less accessible).
• Neuroanatomical Insight: The convergence of effective TMS and tES protocols on the Frontopolar Cortex and DLPFC reinforces the role of executive control and salience networks in addiction recovery.
• Regulatory Impact: The study supports the expansion of regulatory approvals (FDA/CE) for NIBS in SUDs beyond nicotine, potentially paving the way for approvals for cocaine and opioid use disorders based on the robust effect sizes observed.
• Future Directions: Highlights the need for standardized protocols, particularly for alcohol use disorder, and further replication of the high-effect-size dTMS H4 coil findings.

Conclusion: Noninvasive brain stimulation is a potent therapeutic tool for SUDs. While TMS and tES both reduce craving, TMS (specifically multi-session rTMS and dTMS) shows superior efficacy in reducing actual drug consumption and relapse. The identification of the Frontopolar Cortex and Salience Network as key targets offers a clear roadmap for developing next-generation addiction treatments.